Evidence map›Paper›PMID 39974454›Full record

ArticleMaedica2024

Gastric Juice Biomarkers in Gastric Cancer: New Trends?

Georgios D Lianos, Gerasimia D Kyrochristou, Aikaterini D Lianou, Vasileios Tatsis, Dimitrios Schizas, Konstantinos Vlachos, Michail Mitsis

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Maedica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Georgios D LianosDepartment of Surgery, University Hospital of Ioannina, Ioannina, Greece.
Gerasimia D KyrochristouDepartment of Surgery, University Hospital of Ioannina, Ioannina, Greece.
Aikaterini D LianouDepartment of Surgery, University Hospital of Ioannina, Ioannina, Greece.
Vasileios TatsisDepartment of Surgery, University Hospital of Ioannina, Ioannina, Greece.
Dimitrios Schizas1st Department of Surgery, National and Kapodistrian University of Athens,Laikon General Hospital, 11527 Athens, Greece.
Konstantinos VlachosDepartment of Surgery, University Hospital of Ioannina, Ioannina, Greece.
Michail MitsisDepartment of Surgery, University Hospital of Ioannina, Ioannina, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As gastric cancer represents the fifth most common cancer diagnosis and the third leading cause of cancer death worldwide, it remains a current social and health issue. A variety of genetic, epigenetic and environmental factors contribute to the development of gastric cancer, although the etiology remains unclear. Timely diagnosis and appropriate treatment play the most crucial role not only in the containment of morbidity and mortality but also in the prognosis. The establishment of novel non-invasive biomarkers into patient management protocols represents a very promising and challenging approach. In this article, we focus on gastric cancer biomarkers with a special interest in gastric juice that may represent a novel, non-invasive, cost-effective 'liquid biopsy'.

Identifiers

PMID39974454
PMCPMC11834849

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.